EU4Health - Action grants to support actions to improve access to human papillomavirus vaccination

Deadline :
January 25, 2022 5:00 AM

Brussels time

Project Duration:
Funding available:
€1,200,000
Partners required:
Either a sole applicant or a consortium

Funding programme

EU4Health is the EU’s funding programme to deliver on EU health policy and respond to the COVID-19 pandemic. 

Read more about EU4Health here.

Call overview

This call contributes to the design, planning and roll-out of an HPV vaccination campaign at Member State level.

Call summary

The aim of the action is to contribute to the implementation of Europe’s Beating Cancer Plan, which aims to support Member States’ efforts to extend the roll-out of routine HPV vaccination of girls and boys to eliminate cervical cancer and other cancers caused by HPV in the coming decade. 

The action will support civil society organisations, including non-governmental organisations, to complement the Member States’ actions according to national and regional needs related to HPV vaccination policies and programmes. The activities which will be funded will include targeted meetings, workshops, and other initiatives to sharing information with national and regional authorities of Member States, which need to start large-scale HPV vaccination campaigns, with the main objective to receive support through the provision of expertise, best practices, and guidelines covering the planning and roll-out of vaccination campaigns.

Call details

Activities to be funded under this topic:

  • Training (including training of trainers) on how to successfully communicate with parents and patients on HPV vaccination, how to ensure the provision of consistent messages to the public, and the provision of concrete examples on how to support vaccination in other Member States.
  • Recommendations for the ‘bundling’ of all adolescent vaccines, including the HPV vaccine, by establishing a policy to check patients’ immunisation status at every visit and to always recommend and administer vaccines to those in need. 

Eligibility

In order to be eligible for funding, the applicants (beneficiaries and affiliated entities) must: 

  • be legal entities (public or private bodies) created under Union law or an international organisation, or 
  • be established in one of the eligible countries, i.e. EU Member States (including overseas countries and territories linked to it) or eligible non-EU countries

Consortium Composition

Applications by either a sole applicant or by a consortium are acceptable.

Budget

There is an available budget of EUR 1 200 000 and one single proposal will be awarded under this topic.

Project duration

The duration of proposals should range between 12 and 36 months. The recommended length of a project is 24 months.

Apply now

Deadline :
January 25, 2022 5:00 AM

Brussels time

Project Duration:
Funding available:
€1,200,000
Partners required:
Either a sole applicant or a consortium